CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant E Harris, JAMA, August 30, 2023

From the paper: "Based on currently available data, updated COVID-19 vaccines targeting the XBB.1.5 variant are expected to be effective against BA.2.86—a highly mutated new SARS-CoV-2 variant—for reducing severe disease and hospitalization, according to an August 23 US Centers for Disease Control and Prevention (CDC) risk assessment." https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=Infectious%20diseases&query=home